Closed Blood Sampling Systems Market Size, Demand & Growth by 2034

Coverage: By Type (One Handed, Two Handled); End User (Hospitals and Surgical Clinics, Diagnostic Centers, Research and Academic Organizations, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00020216
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 28, 2026
Closed Blood Sampling Systems Market Size, Demand & Growth by 2034
Report Date: April 28, 2026   |   Report Code: TIPRE00020216 Email: sales@theinsightpartners.com

2025 Market Size

US$ 1.33 Bn

Base year value

2034 Forecast

US$ 2.8 Bn

Projected by 2034

CAGR 2026-2034

8.65 %

Growth rate

Addressable Market

US$ 18.54 Bn

(2026-2034)

The Closed Blood Sampling Systems Market size is expected to reach US$ 2.8 Billion by 2034 from US$ 1.33 Billion in 2025. The market is estimated to record a CAGR of 8.65% from 2026 to 2034.

The report is segmented by Type (One Handed, Two Handled). The report is segmented by End User (Hospitals and Surgical Clinics, Diagnostic Centers, Research and Academic Organizations, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Closed Blood Sampling Systems Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Closed Blood Sampling Systems Market Segmentation

Type

  1. One Handed
  2. Two Handled

End User

  1. Hospitals and Surgical Clinics
  2. Diagnostic Centers
  3. Research and Academic Organizations
  4. Others

Market Research Highlights

  • Global market for Closed Blood Sampling Systems was valued at US$ 1.33 Billion in 2025
  • Annual market size is expected to reach US$ 2.80 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 18.54 Billion
  • Market is anticipated to register a CAGR of 8.65% during the forecast period
  • The United States represents a key market, supported by Rising trend in the prevalence of infections and chronic illnesses, Rising Demand for Patient Safety and Prevention of Infections, Health Care Equipment/Devices Market, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Research and Development of Next-Generation Systems, Strategic Collaborations and Partnerships Market Growth Strategies, Rising Importance of Personalized Medicine are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including EDWARDS LIFESCIENCES, MERIT MEDICAL, SMITHS MEDICAL, VELANO VASCULAR, ICU MEDICAL, UTAH MEDICAL PRODUCTS, ASHCON INTERNATIONAL, CARDIOMED SUPPLIES INC., ARGON MEDICAL, ITL BIOMEDICAL, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Closed Blood Sampling Systems Market: Strategic Insights

closed-blood-sampling-systems-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Closed Blood Sampling Systems Market Growth Drivers

  1. Rising trend in the prevalence of infections and chronic illnesses: It has been observed that increasing cases of chronic ailments such as diabetes, cardiovascular diseases, and even infectious diseases have fueled the demand for blood sampling. As these diseases have more monitoring tests imposed on them, the health care providers are forced to embrace systems that minimize the contaminating effect of the environment during collection and handling of samples. Whereby exposure to every possible pathogen is prevented either to the patient or the healthcare worker, closed blood sampling systems are safer.
  2. Rising Demand for Patient Safety and Prevention of Infections: Implementation of patient safety and control of infections during healthcare provision remains a critical issue for most countries. This is because the problem of hospital-acquired infections (HAIs) has not been resolved and the health care seeks for new approaches to prevent the infections. The use of closed blood sampling systems also allows improvement in infection control measures because blood is collected in sterile and sealed systems. This system will not only reduce the risk of sample collector contamination but also reduces the risk of bloodborne pathogen exposure thus promoting patient safety.
  3. Health Care Equipment/Devices Market: Trends and Developments. Technological progress pertaining to medical devices automated blood sampling systems, real time monitoring and links with electronic record systems is some of the key factors fueling the growth of the closed blood sampling systems market. Such technologies enable more accurate, effective and quick blood sampling procedures hence further encouraging the use of closed blood collection systems in the clinics, diagnostic centers and even laboratories. Furthermore, the application of the IoT for the tracking and monitoring of blood samples also improves the overall health care outcomes.

Closed Blood Sampling Systems Market Future Trends

  1. Connection with Digital Health Care Systems: With the ever-evolving conception of healthcare, the adoption of closed blood collecting systems and the e-health paradigm is on the rise. This includes installing features like automatic inputting of data into electronic patient records, monitoring the conditions of the samples (for example, temperature, pH level) in real-time, and tracking the samples over a distance. These integrations improve workflow efficiencies, decrease human error, and assure that blood samples are processed and transported under the appropriate circumstances.
  2. Preference for Disposable and Single-Use Systems: Today, there is an increasing demand for disposable or single-use closed blood sampling systems in almost every healthcare facility. These systems not only help eliminate the chances of cross-contamination but also make the cleaning and management of such systems easy. The use of disposable systems is most warranted in high turnover clinical areas since it speeds up the workflow and promotes the very high standard of hygiene and safety for both patients and healthcare workers.
  3. Introduction of Closed Blood Sampling Systems in Homecare Healthcare Services: The growing trend in the non-institutionalization of patients is increasing the need for closed blood sampling systems that are to be used in the homes and are portable and easy to use. More patients are turning to in-home care and even telemedicine and so there is a need for such systems that perform blood sampling outside the health facilities. Patients and healthcare providers are developing portable closed blood sampling devices to facilitate the safe and uncontaminated collection of blood samples from patients at home for their convenience.

Closed Blood Sampling Systems Market Opportunities

  1. Research and Development of Next-Generation Systems: There continues to be room in the market for the research and development (R&D) of next: generation closed blood sampling systems. In fact, manufacturers are looking for different aspects on how to improve the performance of the CBSS devices for instance, enhancement of their automation, integration with the digital health applications, and decreasing the manufacturing costs. Technologies that enhance the user experience, decrease the time taken to process samples or improve the methods of blood collection are likely to fuel the market growth and further stimulate uptake in the healthcare systems.
  2. Strategic Collaborations and Partnerships Market Growth Strategies: There are market growth strategies, given the strategic collaborations of major players in the healthcare economy, including hospitals, diagnostic labs, manufacturers of medical products, or technology companies. Such partnerships, which have more to do with products in development, clinical studies or distribution networks, should help even more with penetration of closed blood sampling systems into the markets and speed up their uptake in both developed and developing ones.
  3. Rising Importance of Personalized Medicine: Market Growth Factors Include Rising Demand for Closed Blood Sampling Among Other Technologies: The changing trend in the provision of healthcare that is more focused on personalization and precision diagnosis has huge benefits that can be derived in these systems. It is indisputable that such tests carried out for other purposes such as genetic tests, whereby physicians are ever relying on more and more genetic tests, the need for clean and contamination: free blood samples becomes increasingly paramount. In this respect, closed blood sampling systems are critical in preserving the samples needed for the intended specific individual medical testing, which in turn presents a viable opportunity in the market.

Closed Blood Sampling Systems Market Report Scope

Report Attribute Details
Market size in 2025 US$ 1.33 Billion
Market Size by 2034 US$ 2.8 Billion
Global CAGR (2026 - 2034) 8.65%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Type
  • One Handed
  • Two Handled
By End User
  • Hospitals and Surgical Clinics
  • Diagnostic Centers
  • Research and Academic Organizations
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • EDWARDS LIFESCIENCES
  • MERIT MEDICAL
  • SMITHS MEDICAL
  • VELANO VASCULAR
  • ICU MEDICAL
  • UTAH MEDICAL PRODUCTS
  • ASHCON INTERNATIONAL
  • CARDIOMED SUPPLIES INC.
  • ARGON MEDICAL
  • ITL BIOMEDICAL

Closed Blood Sampling Systems Market Players Density: Understanding Its Impact on Business Dynamics

The Closed Blood Sampling Systems Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

closed-blood-sampling-systems-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Closed Blood Sampling Systems Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Closed Blood Sampling Systems Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Players operating in the market are EDWARDS LIFESCIENCES, MERIT MEDICAL, SMITHS MEDICAL, VELANO VASCULAR, ICU MEDICAL, UTAH MEDICAL PRODUCTS, ASHCON INTERNATIONAL, CARDIOMED SUPPLIES INC., ARGON MEDICAL, ITL BIOMEDICAL

Two-handled segment, by type, dominated the market in 2025.

The Closed Blood Sampling Systems Market is estimated to witness a CAGR of 8.65% from 2026 to 2034

North America region dominated the Closed Blood Sampling Systems market in 2025.

Research and Development of Next-Generation Systems act as a opportunity for growth of the market in forecast period.

The major factors driving the Closed Blood Sampling Systems market are:

1. There is a rising trend in the prevalence of infections and chronic illnesses

2. Health Care Equipment/Devices Market
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA